Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

Compare

1.530

+0.020 (1.32%)

At close: Oct 9, 2025, 4:00 PM EDT

1.530

0.00 (-0.01%)

After-hours: Oct 9, 2025, 4:12 PM EDT

PACB Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	156.11	154.01	200.52	128.3	130.51	78.89	Upgrade
Revenue Growth (YoY)	-17.35%	-23.19%	56.29%	-1.69%	65.43%	-13.20%	Upgrade
Cost of Revenue	113.09	106.34	142.32	74.83	71.35	46.33	Upgrade
Gross Profit	43.02	47.67	58.2	53.47	59.17	32.57	Upgrade
Selling, General & Admin	174.23	175.02	169.82	160.85	124.12	72.8	Upgrade
Research & Development	108.36	134.92	187.17	193	112.9	64.15	Upgrade
Other Operating Expenses	1	1	3.44	3.71	-	-	Upgrade
Operating Expenses	664.7	338.34	368.56	358.29	237.33	136.95	Upgrade
Operating Income	-621.68	-290.66	-310.37	-304.82	-178.16	-104.39	Upgrade
Interest Expense	-9.77	-13.41	-14.34	-14.69	-12.53	-0.27	Upgrade
Other Non Operating Income (Expenses)	8.4	10.74	19.84	7.39	4.1	1.95	Upgrade
EBT Excluding Unusual Items	-623.05	-293.34	-304.86	-312.12	-186.59	-102.7	Upgrade
Merger & Restructuring Charges	20.7	-	-9.04	-	-83.13	34	Upgrade
Impairment of Goodwill	-51.3	-144.5	-	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	8.45	13.04	12.84	0.24	-4.01	0.11	Upgrade
Asset Writedown	-55	-40	-	-	-	-	Upgrade
Other Unusual Items	173.89	155.26	-17.09	-2.38	-1.14	98	Upgrade
Pretax Income	-526.31	-309.54	-318.16	-314.25	-274.87	29.4	Upgrade
Income Tax Expense	0.05	0.32	-11.42	-	-93.65	-	Upgrade
Net Income	-526.36	-309.85	-306.74	-314.25	-181.22	29.4	Upgrade
Net Income to Common	-526.36	-309.85	-306.74	-314.25	-181.22	29.4	Upgrade
Shares Outstanding (Basic)	288	274	254	225	204	165	Upgrade
Shares Outstanding (Diluted)	288	274	254	225	204	175	Upgrade
Shares Change (YoY)	8.33%	8.22%	12.95%	10.00%	16.67%	14.71%	Upgrade
EPS (Basic)	-1.83	-1.13	-1.21	-1.40	-0.89	0.18	Upgrade
EPS (Diluted)	-1.83	-1.13	-1.21	-1.40	-0.89	0.17	Upgrade
Free Cash Flow	-152.32	-212.25	-268.02	-279.96	-117.11	18.46	Upgrade
Free Cash Flow Per Share	-0.53	-0.77	-1.06	-1.25	-0.57	0.11	Upgrade
Gross Margin	27.56%	30.95%	29.02%	41.68%	45.33%	41.28%	Upgrade
Operating Margin	-398.23%	-188.73%	-154.78%	-237.58%	-136.51%	-132.31%	Upgrade
Profit Margin	-337.17%	-201.18%	-152.97%	-244.93%	-138.85%	37.27%	Upgrade
Free Cash Flow Margin	-97.57%	-137.81%	-133.66%	-218.20%	-89.73%	23.40%	Upgrade
EBITDA	-225.74	-249.48	-290.64	-294.43	-170.58	-97.96	Upgrade
EBITDA Margin	-144.60%	-161.98%	-144.94%	-229.47%	-130.70%	-124.16%	Upgrade
D&A For EBITDA	395.94	41.19	19.72	10.39	7.58	6.43	Upgrade
EBIT	-621.68	-290.66	-310.37	-304.82	-178.16	-104.39	Upgrade
EBIT Margin	-	-188.73%	-154.78%	-237.58%	-136.51%	-132.31%	Upgrade
Revenue as Reported	156.11	154.01	200.52	128.3	130.51	78.89	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q